A phase II trial of irinotecan, 5-fluorouracil and leucovorin combined with celecoxib and glutamine as first-line therapy for advanced colorectal cancer. [electronic resource]
Producer: 20050920Description: 63-70 p. digitalISSN:- 0030-2414
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Celecoxib
- Colorectal Neoplasms -- drug therapy
- Cyclooxygenase Inhibitors -- therapeutic use
- Diarrhea -- chemically induced
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Glutamine -- therapeutic use
- Humans
- Irinotecan
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Pyrazoles -- therapeutic use
- Sulfonamides -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.